Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Open Femur Fracture Surgery
NCT03679481Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tranexamic acid, sponsored by UTHealth Houston. Planned start Apr 2020; status: withdrawn.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT03679481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03679481.